Amdocs Limited Reports Quarterly Revenue of $690 Million Key highlights:

- Third quarter revenue of $690 million, within the $670-$690 million guidance range

- Third quarter non-GAAP operating income of $124 million; non-GAAP operating margin of 18.0%; GAAP operating income of $93 million

- Third quarter diluted non-GAAP EPS of $0.53, excluding acquisition-related costs and equity-based compensation expense, net of related tax effects

- Diluted GAAP EPS of $0.42 for the third quarter

- Free cash flow of $96 million for the third quarter

- 12-month backlog of $2.37 billion at the end of the third quarter

- Fourth quarter fiscal 2009 guidance: Expected revenue of approximately $670-$690 million and diluted non-GAAP EPS of $0.47-$0.51, excluding acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.34-$0.39

ST. LOUIS, July 22 /PRNewswire-FirstCall/ -- Amdocs Limited (NYSE: DOX) today reported that for its fiscal third quarter ended June 30, 2009, revenue was $690.3 million, a decrease of 15.9% from last year's third quarter and down 2.9% sequentially. Net income on a non-GAAP basis was $108.6 million, or $0.53 per diluted share, compared to non-GAAP net income of $132.5 million, or $0.61 per diluted share, in the third quarter of fiscal 2008. Non-GAAP net income excludes amortization of purchased intangible assets and equity-based compensation expenses of $23.0 million, net of related tax effects, in the third quarter of fiscal 2009 and excludes such amortization, in-process research and development write-off and equity-based compensation expenses of $31.8 million, net of related tax effects, in the third quarter of fiscal 2008. The Company's GAAP net income for the third quarter of fiscal 2009 was $85.5 million, or $0.42 per diluted share, compared to GAAP net income of $100.7 million, or $0.46 per diluted share, in the prior year's third quarter.

"We are pleased with our results for the third fiscal quarter, particularly in light of the on-going strain in the global economy. Favorable foreign currency movements increased third quarter revenue and EPS relative to our expectations for the quarter. Even without currency benefits, our results were at or above the mid-point of our guidance ranges. Additionally, backlog remained stable and we continued to meet our profit and cash flow objectives, all of which are encouraging," said Dov Baharav, chief executive officer of Amdocs Management Limited.

Baharav continued, "Demand conditions, however, remain weak, particularly for large transformational projects, as our customers manage their budgets tightly. As a result, we anticipate that our revenue may continue to trend down sequentially, albeit at a moderating pace, until we see demand improve. This view is reflected in our fourth fiscal quarter guidance, and we believe this trend could persist into early fiscal 2010."

Baharav concluded, "While the pace of new deal activity is still slow, we signed important deals in the third quarter. We saw relative strength in our cable, managed services and Interactive domains, highlighted by several key wins."

  • For J:COM, Japan's largest multiple system and channel operator, Amdocs is fully modernizing the customer's billing system and replacing a competitor's CRM system, all based on the CES 7.5 product platform.
  • Amdocs signed a six-year managed services contract with Elisa, a Finnish service provider, to consolidate eight billing systems across Elisa's wireless, wireline, Internet and cable TV lines of business onto the Amdocs Billing platform, as well as, deploy Amdocs Enterprise Product Catalog 7.5 to centralize information from five different existing catalogs. The new contract builds on an existing relationship with the customer, where Amdocs billing, ordering and CRM systems were previously deployed to support Elisa's wireless operations.
  • Within Interactive, Amdocs signed several contracts during the third quarter, including two within the emerging markets. In Latin America, Amdocs signed a key contract with a large service provider to support its wireless portal development, digital commerce and personalization across all of its affiliates. Importantly, the deal included products based on both the QPass and ChangingWorlds technologies, demonstrating early synergies within our Interactive portfolio. Amdocs also signed two additional ChangingWorlds contracts, both in the Asia-Pacific region.

Free cash flow was $96 million for the quarter, comprised of cash flow from operations of $114 million less approximately $18 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.37 billion at the end of the third quarter of fiscal 2009.

Financial Outlook

Amdocs expects that revenue for the fourth quarter of fiscal 2009 will be approximately $670-$690 million. Amdocs expects diluted earnings per share on a non-GAAP basis for the fourth quarter to be $0.47-$0.51, excluding acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the fourth quarter will be $0.34-$0.39.

Amdocs will host a conference call on July 22, 2009 at 5 p.m. Eastern Time to discuss the Company's third quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income. These non-GAAP measures exclude the following items:

  • amortization of purchased intangible assets;
  • in-process research and development write-off;
  • restructuring charges;
  • equity-based compensation expense; and
  • tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income, when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets, in-process research and development write-off, restructuring charges, equity-based compensation expense, and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments.

Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About Amdocs

Amdocs is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and the intentional customer experience((TM)) - at every point of service. Amdocs provides solutions that deliver customer experience excellence, combining the software, service and expertise to help its customers execute their strategies and achieve service, operational and financial excellence. A global company with revenue of $3.16 billion in fiscal 2008, Amdocs has approximately 17,000 employees and serves customers in more than 50 countries around the world. For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2008 filed on December 8, 2008 and in our quarterly 6-K furnished on February 9, 2009 and May 12, 2009.

                                    AMDOCS LIMITED

                          Consolidated Statements of Income
                        (in thousands, except per share data)

                                 Three months ended      Nine months ended
                                       June 30,               June 30,
                                --------------------  -----------------------
                                   2009       2008        2009        2008
                                ---------  ---------  -----------  ----------

    Revenue:
      License                   $  26,075  $  35,244  $  107,879   $   93,570
      Service                     664,190    785,044   2,047,309    2,243,249
                                ---------  ---------  -----------  ----------
                                  690,265    820,288   2,155,188    2,336,819
    Operating expenses:
      Cost of license                 537        555       2,097        2,267
      Cost of service             441,777    528,437   1,381,825    1,493,134
      Research and development     51,134     56,137     160,113      168,240
      Selling, general and
       administrative              81,732    104,632     256,305      300,963
      Amortization of purchased
       intangible assets           21,839     22,796      63,594       66,302
      Restructuring charges and
       in-process research and
       development (1)                  -      1,780      20,780        1,780
                                ---------  ---------  -----------  ----------
                                  597,019    714,337   1,884,714    2,032,686
                                ---------  ---------  -----------  ----------
    Operating income               93,246    105,951     270,474      304,133

    Interest income (expense)
     and other, net                 2,514      6,159      (1,014)      23,797
                                ---------  ---------  -----------  ----------
    Income before income taxes     95,760    112,110     269,460      327,930

    Income taxes                   10,212     11,438      29,035       31,735
                                ---------  ---------  -----------  ----------
    Net income                  $  85,548  $ 100,672  $  240,425   $  296,195
                                =========  =========  ===========  ==========
    Basic earnings per share    $    0.42  $    0.49  $     1.19   $     1.43
                                =========  =========  ===========  ==========
    Diluted earnings per
     share (2)                  $    0.42  $    0.46  $     1.16   $     1.36
                                =========  =========  ===========  ==========
    Basic weighted average
     number of shares
     outstanding                  202,750    206,329     202,624      207,069
                                =========  =========  ===========  ==========
    Diluted weighted average
     number of shares
     outstanding                  203,515    219,120     208,514      220,315
                                =========  =========  ===========  ==========

    (1) Restructuring charges and in-process research and development for
        the nine months ended June 30, 2009 includes restructuring charges
        of $15,140, and in-process research and development of $5,640.

    (2) To reflect the impact of assumed conversion of the convertible notes,
        $0 and $1,486, representing interest expense and amortization of
        issuance costs, were added back to net income for the three and nine
        months ended June 30, 2009, respectively, and $985 and $2,955 were
        added back to net income for the three and nine months ended June
        30, 2008, respectively, for the purpose of computing diluted
        earnings per share.



                                AMDOCS LIMITED
                          Selected Financial Metrics
                     (in thousands, except per share data)

                           Three months ended        Nine months ended
                                June 30,                  June 30,
                         ---------------------   -------------------------
                            2009        2008         2009          2008
                         ---------   ---------   -----------   -----------

    Revenue              $ 690,265   $ 820,288   $ 2,155,188   $ 2,336,819

    Non-GAAP operating
     income                124,482     146,608       388,179       415,925

    Non-GAAP net income    108,555     132,463       329,680       382,400

    Non-GAAP diluted
     earnings per
     share (1)           $    0.53   $    0.61   $      1.59   $      1.75

    Diluted weighted
     average number of
     shares outstanding    203,515     219,120       208,514       220,315

    (1) To reflect the impact of assumed conversion of the convertible
        notes, $0 and $1,486, representing interest expense and
        amortization of issuance costs, were added back to net income for
        the three and nine months ended June 30, 2009, respectively, and
        $985 and $2,955 were added back to net income for the three and
        nine months ended June 30, 2008, respectively, for the purpose of
        computing diluted earnings per share.



                                   AMDOCS LIMITED
          Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
                                   (in thousands)

                                        Three months ended
                                           June 30, 2009
                        ------------------------------------------------------
                                        Reconciliation items
                                 ---------------------------------
                                 Amortization
                                      of
                                   purchased  Equity based
                                  intangible  compensation   Tax
                           GAAP     assets      expense     effect   Non-GAAP
                        ------------------------------------------------------
    Operating
     expenses:
      Cost of license   $    537  $      -      $     -   $      -    $    537
      Cost of service    441,777         -       (6,115)         -     435,662
      Research and
       development        51,134         -       (1,238)         -      49,896
      Selling, general
       and
       administrative     81,732         -       (2,044)         -      79,688
      Amortization of
       purchased
       intangible
       assets             21,839   (21,839)           -          -           -
                        ------------------------------------------------------
    Total operating
     expenses            597,019   (21,839)      (9,397)         -     565,783
                        ------------------------------------------------------
                        ------------------------------------------------------
    Operating income      93,246    21,839        9,397          -     124,482
                        ------------------------------------------------------
                        ------------------------------------------------------
    Income taxes          10,212         -            -      8,229      18,441
                        ------------------------------------------------------
                        ------------------------------------------------------
    Net income          $ 85,548  $ 21,839      $ 9,397   $ (8,229)  $ 108,555
                        ------------------------------------------------------



                                     Three months ended
                                        June 30, 2008
                  ------------------------------------------------------------
                                        Reconciliation items
                          --------------------------------------------
                          Amortization
                               of      In-process
                            purchased   research  Equity based
                           intangible     and     compensation  Tax     Non-
                     GAAP    assets    development  expense    effect   GAAP
                  ------------------------------------------------------------
    Operating
     expenses:
      Cost of
       license    $    555  $     -     $     -    $     -    $    -  $    555
      Cost of
       service     528,437        -           -     (5,998)        -   522,439
      Research
       and
       development  56,137        -           -     (1,104)        -    55,033
      Selling,
       general
       and
       administ-
       rative      104,632        -           -     (8,979)        -    95,653
      Amortization
       of
       purchased
       intangible
       assets       22,796  (22,796)          -          -         -         -
      Restruct-
       uring
       charges and
       in-process
       research
       and
       development   1,780        -      (1,780)         -         -         -
                  ------------------------------------------------------------
    Total
     operating
     expenses      714,337  (22,796)     (1,780)   (16,081)        -   673,680
                  ------------------------------------------------------------
                  ------------------------------------------------------------
    Operating
     income        105,951   22,796       1,780     16,081         -   146,608
                  ------------------------------------------------------------
                  ------------------------------------------------------------
    Income
     taxes          11,438        -           -          -     8,866    20,304
                  ------------------------------------------------------------
                  ------------------------------------------------------------
    Net income    $100,672 $ 22,796     $ 1,780   $ 16,081   $(8,866) $132,463
                  ------------------------------------------------------------



                                   AMDOCS LIMITED
         Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
                                   (in thousands)

                                         Nine months ended
                                           June 30, 2009
               ---------------------------------------------------------------
                                       Reconciliation items
                          -----------------------------------------
                                      Restruct-
                                        uring
                                       charges
                           Amortiz-      and      Equity
                           ation of  in-process    based
                           purchased  research    compen-
                          intangible     and      sation     Tax      Non-
                    GAAP    assets   development  expense   effect    GAAP
               ---------------------------------------------------------------
    Operating
     expenses:
      Cost of
       license $    2,097  $      -  $      -   $      -  $      -  $    2,097
      Cost of
       service  1,381,825         -         -    (16,776)        -   1,365,049
      Research
       and
       develop-
       ment       160,113         -         -     (3,277)        -     156,836
      Selling,
       general
       and
       administ-
       rative     256,305         -         -    (13,278)        -     243,027
      Amortiz-
       ation
       of
       purchased
       intangible
       assets      63,594   (63,594)        -          -         -           -
      Restruct-
       uring
       charges
       and
       in-
       process
       research
       and
       develop-
       ment        20,780         -   (20,780)         -         -           -
               ---------------------------------------------------------------
    Total
     operating
     expenses   1,884,714   (63,594)  (20,780)   (33,331)        -   1,767,009
               ---------------------------------------------------------------
               ---------------------------------------------------------------
    Operating
     income       270,474    63,594    20,780     33,331         -     388,179
               ---------------------------------------------------------------
               ---------------------------------------------------------------
    Income
     taxes         29,035         -         -          -    28,450      57,485
               ---------------------------------------------------------------
               ---------------------------------------------------------------
    Net
     income    $  240,425  $ 63,594  $ 20,780   $ 33,331  $(28,450) $  329,680
               ---------------------------------------------------------------



                                           Nine months ended
                                             June 30, 2008
               ---------------------------------------------------------------
                                       Reconciliation items
                          ----------------------------------------

                            Amortiz-              Equity
                            ation of In-process   based
                           purchased  research   compen-
                          intangible    and      sation    Tax        Non-
                     GAAP   assets   development expense  effect      GAAP
               ---------------------------------------------------------------
    Operating
     expenses:
      Cost of
       license $    2,267  $      -  $      -  $      -  $       -  $    2,267
      Cost of
       service  1,493,134         -         -   (17,711)         -   1,475,423
      Research
       and
       develop-
       ment       168,240         -         -    (3,626)         -     164,614
      Selling,
       general
       and
       administ-
       rative     300,963         -         -   (22,373)         -     278,590
      Amortiz-
       ation
       of
       purchased
       intangible
       assets      66,302   (66,302)        -         -          -           -
      Restruct-
       uring
       charges
       and
       in-
       process
       research
       and
       develop-
       ment         1,780         -    (1,780)        -          -           -
               ---------------------------------------------------------------
    Total
     operating
     expenses   2,032,686   (66,302)   (1,780)  (43,710)         -   1,920,894
               ---------------------------------------------------------------
               ---------------------------------------------------------------
    Operating
     income       304,133    66,302     1,780    43,710          -     415,925
               ---------------------------------------------------------------
               ---------------------------------------------------------------
    Income
     taxes         31,735         -         -         -     25,587      57,322
               ---------------------------------------------------------------
               ---------------------------------------------------------------
    Net
     income    $  296,195  $ 66,302    $1,780   $43,710   $(25,587) $  382,400
               ---------------------------------------------------------------



                                    AMDOCS LIMITED
                        Condensed Consolidated Balance Sheets
                                    (in thousands)

                                                           As of
                                                  ---------------------------
                                                    June 30,    September 30,
                                                      2009           2008
                                                  -----------   -------------

    ASSETS

    Current assets
    Cash, cash equivalents and short-term
     interest-bearing investments                 $ 1,280,289    $ 1,244,378
    Accounts receivable, net, including unbilled
     of $44,439 and $48,264 respectively              507,507        573,764
    Deferred income taxes and taxes receivable        106,906         84,515
    Prepaid expenses and other current assets          95,224        102,930
                                                  -----------   -------------
      Total current assets                          1,989,926      2,005,587

    Equipment and leasehold improvements, net         279,247        317,081
    Goodwill and other intangible assets, net       1,790,572      1,796,922
    Other noncurrent assets                           439,104        459,473
                                                  -----------   -------------
    Total assets                                  $ 4,498,849    $ 4,579,063
                                                  ===========   =============

    LIABILITIES AND SHAREHOLDERS' EQUITY

    Current liabilities
    Accounts payable and accruals                 $   429,533    $   600,285
    Short-term portion of financing arrangements        1,037          1,660
    Deferred revenue                                  185,097        197,851
    Deferred income taxes and taxes payable            24,358         30,228
                                                  -----------   -------------
      Total current liabilities                       640,025        830,024

    0.50% Convertible notes                             1,020        450,000
    Long-term loan                                    300,000              -
    Noncurrent liabilities and other                  483,135        493,848
    Shareholders' equity                            3,074,669      2,805,191
                                                  -----------   -------------
    Total liabilities and shareholders' equity    $ 4,498,849    $ 4,579,063
                                                  ===========   =============



                                 AMDOCS LIMITED
                      Consolidated Statements of Cash Flows
                                 (in thousands)

                                                Nine months ended June 30,
                                                --------------------------
                                                    2009           2008
                                                -----------     ----------

    Cash Flow from Operating Activities:
    Net income                                   $ 240,425      $ 296,195
    Reconciliation of net income to net cash
     provided by operating activities:
      Depreciation and amortization                147,869        143,978
      In-process research and development            5,640          1,780
      Loss (gain) on sale of equipment                  67            (55)
      Equity-based compensation expense             33,331         43,710
      Deferred income taxes                         13,097          6,378
      Gain on repurchase of convertible notes       (2,185)             -
      Excess tax benefit from equity-based
       compensation                                    (10)          (209)
      Loss from short-term interest-bearing
       investments                                   5,821          1,771
    Net changes in operating assets and
     liabilities, net of amounts acquired:
      Accounts receivable                           63,843       (148,472)
      Prepaid expenses and other current assets      6,875          8,166
      Other noncurrent assets                        2,263        (40,420)
      Accounts payable, accrued expenses and
       accrued personnel                          (139,466)       (20,728)
      Deferred revenue                               8,815         12,283
      Income taxes payable                         (12,638)       (25,429)
      Noncurrent liabilities and other             (38,268)        26,590
                                                -----------     ----------
    Net cash provided by operating activities      335,479        305,538
                                                -----------     ----------

    Cash Flow from Investing Activities:
    Proceeds from sale of equipment and
     leasehold improvements                          429          1,103
    Payments for purchase of equipment and
     leasehold improvements                      (65,474)      (101,530)
    Proceeds from sale of short-term
     interest-bearing investments                601,844        575,602
    Purchase of short-term interest-bearing
     investments                                (676,472)      (513,462)
    Net cash paid for acquisition                (61,890)       (56,970)
                                               -----------     ----------
    Net cash used in investing activities       (201,563)       (95,257)
                                               -----------     ----------

    Cash Flow from Financing Activities:
    Borrowing under long-term financing
     arrangements                                450,000              -
    Payments under long-term financing
     arrangements                               (150,000)             -
    Redemption of convertible notes             (330,780)          (174)
    Repurchase of convertible notes             (116,015)             -
    Repurchase of shares                         (20,014)      (172,339)
    Payments under capital lease and
     short-term financing arrangements            (3,632)             -
    Borrowing under short-term financing
     arrangements                                    540              -
    Proceeds from employee stock options
     exercised                                     2,026         33,755
    Excess tax benefit from equity-based
     compensation                                     10            209
                                               -----------     ----------
    Net cash used in financing activities       (167,865)      (138,549)
                                               -----------     ----------

    Net (decrease) increase in cash and cash
     equivalents                                   (33,949)        71,732
    Cash and cash equivalents at beginning of
     period                                        718,850        615,501
                                                -----------     ----------
    Cash and cash equivalents at end of
     period                                      $ 684,901      $ 687,233
                                                ===========     ==========



                                     AMDOCS LIMITED
                                Supplementary Information
                                      (in millions)

                    ----------------------------------------------------------
                                          Three months ended
                    ----------------------------------------------------------
                    June 30,  March 31,  December 31,  September 30,  June 30,
                      2009      2009         2008          2008         2008
                    --------  ---------  ------------  -------------  --------
      North America  $ 527.7   $ 539.8     $ 561.6        $ 558.7     $ 570.5
      Europe            84.4     105.0       111.4          150.9       133.0
      Rest of World     78.2      66.3        80.8          115.7       116.8
                    --------  ---------  ------------  -------------  --------
    Total Revenue    $ 690.3   $ 711.1     $ 753.8        $ 825.3     $ 820.3
                    ========  =========  ============  =============  ========


                    ----------------------------------------------------------
                                        Three months ended
                    ----------------------------------------------------------
                    June 30,  March 31,  December 31,  September 30,  June 30,
                      2009      2009         2008          2008         2008
                    --------  ---------  ------------  -------------  --------
      Customer
       Experience    $ 647.9   $ 668.0     $ 701.0        $ 756.5     $ 756.9
      Systems
      Directory         42.4      43.1        52.8           68.8        63.4
                    --------  ---------  ------------  -------------  --------
    Total Revenue    $ 690.3   $ 711.1     $ 753.8        $ 825.3     $ 820.3
                    ========  =========  ============  =============  ========


                    ----------------------------------------------------------
                                                As of
                    ----------------------------------------------------------
                    June 30,  March 31,  December 31,  September 30,  June 30,
                      2009      2009         2008          2008         2008
                    --------  ---------  ------------  -------------  --------
    12-Month
     Backlog         $ 2,370   $ 2,370     $ 2,400        $ 2,420     $ 2,420
                    --------  ---------  ------------  -------------  --------

SOURCE Amdocs Limited



RELATED LINKS
http://www.amdocs.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.